ETON PHARMACEUTICALS INC. - COMMON STOCK
17.27
11-February-25 15:45:00
15 minutes delayed
Stocks
+0.11
+0.64%
Today's range
16.71 - 17.44
ISIN
N/A
Source
NASDAQ
-
Eton Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results
14 Mar 2024 15:01:00 By Nasdaq GlobeNewswire
-
29 Feb 2024 15:01:00 By Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Awarded U.S. Patent for Proprietary Hydrocortisone Oral Liquid Formulation
21 Feb 2024 05:50:00 By Nasdaq GlobeNewswire
-
02 Feb 2024 05:50:00 By Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Reports Third Quarter 2023 Financial Results
09 Nov 2023 15:01:00 By Nasdaq GlobeNewswire
-
Eton Pharmaceuticals to Report Third Quarter 2023 Financial Results on Thursday, November 9, 2023
30 Oct 2023 05:50:00 By Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Announces Acquisition of FDA-Approved Ultra-Rare Disease Product Nitisinone
04 Oct 2023 05:50:00 By Nasdaq GlobeNewswire
-
Eton Pharmaceuticals to Present at the H.C. Wainwright 25th Annual Global Investment Conference
23 Aug 2023 05:50:00 By Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Reports Second Quarter 2023 Financial Results
10 Aug 2023 15:01:00 By Nasdaq GlobeNewswire
-
Eton Pharmaceuticals to Report Second Quarter 2023 Financial Results on Thursday, August 10, 2023
01 Aug 2023 15:05:00 By Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Receives Complete Response Letter (CRL) for Dehydrated Alcohol Injection
28 Jun 2023 05:50:00 By Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Reports First Quarter 2023 Financial Results
11 May 2023 15:01:01 By Nasdaq GlobeNewswire
-
10 May 2023 05:50:00 By Nasdaq GlobeNewswire
-
Eton Pharmaceuticals to Report First Quarter 2023 Financial Results on Thursday, May 11, 2023
03 May 2023 15:05:00 By Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Reports Fourth Quarter 2022 Financial Results
16 Mar 2023 15:01:00 By Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Announces Acquisition of Rare Disease Product Candidate ET-600
15 Mar 2023 05:50:00 By Nasdaq GlobeNewswire
-
Eton Pharmaceuticals to Report Fourth Quarter 2022 Financial Results on Thursday, March 16, 2023
07 Mar 2023 15:05:00 By Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Announces FDA Acceptance of NDA Response for Dehydrated Alcohol Injection
11 Jan 2023 05:50:00 By Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Reports Third Quarter 2022 Financial Results
10 Nov 2022 15:05:01 By Nasdaq GlobeNewswire
-
Eton Pharmaceuticals to Report Third Quarter 2022 Financial Results on Thursday, November 10, 2022
02 Nov 2022 15:05:00 By Nasdaq GlobeNewswire